Gilead’s new hepatitis C triple therapy Vosevi has been approved in the US, and will largely meet the needs of patients with difficult to treat forms of the disease. The FDA approved Vosevi ...

Gilead’s Trodelvy has another string to its bow after FDA approval in patients with advanced metastatic urothelial cancer. Trodelvy (sacituzumab govitecan) has been approved for locally advanced or ...